Sort
64,565 grants matching “drug discovery”
UHTS Implementation(Florida)
$948,773Peter Simmons Hodder · Scripps Research Institute, The · U54 · FY2012 · MH
Administration and Mgmt (California)
$948,773Hugh Rosen · Scripps Research Institute, The · U54 · FY2012 · MH
Exploration, conservation, & development of marine biodiversity in Fiji and the S
$948,534Mark E Hay · Georgia Institute Of Technology · U19 · FY2018 · TW
Biological annotation of TCGA data
$948,524Gordon B. Mills · University Of Tx Md Anderson Can Ctr · U01 · FY2012 · CA
CATALYTIC METHODS FOR ORGANIC SYNTHESIS
$948,497Stephen L Buchwald · Massachusetts Institute Of Technology · R37 · FY2007 · GM
Clinical study of aerosolized KL4 surfactant for neonatal RDS and BPD prevention
$948,310Robert Segal · Windtree Therapeutics, Inc. · R44 · FY2017 · HL
Identifying chemical probes against all essential genes
$948,179Ronald Wayne Davis · Stanford University · R01 · FY2007 · HG
The von Hippel-Lindau Tumor Suppressor Gene and Kidney Cancer: Insights into Oxygen Sensing and Treating Cancers Caused by Undruggable Mutations
$947,910William G Kaelin · Dana-Farber Cancer Inst · R35 · FY2024 · CA
Identification of Cooperative Genetic Alterations in the Pathogenesis of Oral Cancer
$947,802John B Sunwoo · Stanford University · U01 · FY2016 · DE
Inhibitors and Probes of HIV-1 Cell Fusion
$947,627Carole Bewley · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
Identification and Development of Anti-Flavivirus Lead Drug Candidates
$947,621Jay A Nelson · University Of Alabama At Birmingham · U19 · FY2017 · AI
Complementation Assay for G protein linked Receptors
$947,532Discoverx Corporation · R44 · FY2002 · DA
NOVEL STRATEGIES FOR PLANT-DERIVED ANTICANCER AGENTS
$947,449Ohio State University · U19 · FY2004 · CA
DEVELOPMENTAL FUNDS (Core 002)
$947,406Henry Shelton Earp · Univ Of North Carolina Chapel Hill · P30 · FY2017 · CA
Centenarian Consortium Project
$947,394Thomas T Perls · California Pacific Med Ctr Res Institute · U19 · FY2021 · AG
Accurate Point of Care Liver Disease Diagnostics, Phase II
$947,354Pablo J Prado · Livivos Inc. · R44 · FY2025 · DK
Core B: University of Kentucky Alzheimer's Disease Core Center
$947,257Gregory A Jicha · University Of Kentucky · P30 · FY2023 · AG
Uncovering the parasite and host determinants of Plasmodium vivax hypnozoite formation and development using single cell sequencing and human liver-chimeric mice
$946,707Ashley M Vaughan · Seattle Children'S Hospital · R01 · FY2022 · AI
DNA Topoisomerases as nuclear and mitochondrial targets of Anticancer Drugs
$946,675Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Mechanistic studies of chromatin modification in transcription regulation
$946,600Cynthia Wolberger · Johns Hopkins University · R35 · FY2024 · GM
Alzheimer's Disease Neuroimaging Initiative
$946,418Michael W Weiner · Northern California Institute/Res/Edu · U19 · FY2017 · AG
Identifying novel anti-infectives by high through-put screening in whole animals
$946,258Frederick M Ausubel · Massachusetts General Hospital · R01 · FY2013 · AI
Cellular Interactions with Thrombospondin
$945,821David D Roberts · Division Of Clinical Sciences - Nci · ZIA · FY2013 · CA
Closing the Gaps on Buruli Ulcer Diagnosis, Treatment, and Prevention
$945,739Eric L Nuermberger · Johns Hopkins University · R01 · FY2016 · AI
Proteomic Strategies for AIDS and Drug Abuse - HIV and METH CNS Synergy
$945,515Howard S. Fox · University Of Nebraska Medical Center · P01 · FY2010 · DA